Close Menu

epidermal growth factor receptor mutation

Identification of Epidermal Growth Factor Receptor Mutations and Anaplastic Lymphoma Kinase Gene Rearrangement in Lung Adenocarcinomas

DOI: 
10.7727/wimj.2018.065
Synopsis: 
The identification of molecular alterations has an important therapeutic implication in patients with lung adenocarcinomas. In this study, we presented our experience with the identification of EGFR and ALK mutations using tissue specimens of primary and metastatic lung adenocarcinomas.

ABSTRACT

Objective: The identification of molecular alterations has an important therapeutic implication in lung adenocarcinoma patients. Herein, we presented our experience with the identification of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase(ALK) mutations in primary and metastatic lung adenocarcinomas.

Accepted: 
08 May, 2018
PDF Attachment: 
Journal Sections: 
Journal Authors: 
e-Published: 15 Feb, 2019

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Subscribe to RSS - epidermal growth factor receptor mutation
Top of Page